Guest guest Posted January 18, 2009 Report Share Posted January 18, 2009 Goode news? . . . Ralph W. Moss, Ph.D. Weekly CancerDecisions.com Newsletter #375 01/18/09 CANCER DECISIONS FREE WEEKLY NEWSLETTER We are gratified and excited by the announcement this week that the Food and Drug Administration (FDA) has reached an agreement with the Burzynski Research Institute, Inc., for the design of a phase III trial of antineoplaston therapy for the treatment of diffuse intrinsic brainstem glioma, a rare but highly aggressive form of childhood brain cancer. To read this week's newsletter, please click or go to: http://www.cancerdecisions.com/011809.html Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.